These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 33098703)

  • 21. Prebiotics, Prosynbiotics and Synbiotics: Can They Reduce Plasma Oxidative Stress Parameters? A Systematic Review.
    Salehi-Abargouei A; Ghiasvand R; Hariri M
    Probiotics Antimicrob Proteins; 2017 Mar; 9(1):1-11. PubMed ID: 28044254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probiotics for induction of remission in ulcerative colitis.
    Mallon P; McKay D; Kirk S; Gardiner K
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005573. PubMed ID: 17943867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients.
    Jonkers D; Penders J; Masclee A; Pierik M
    Drugs; 2012 Apr; 72(6):803-23. PubMed ID: 22512365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.
    Hedin C; Whelan K; Lindsay JO
    Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probiotics for inflammatory bowel diseases: a promising adjuvant treatment.
    Coqueiro AY; Raizel R; Bonvini A; Tirapegui J; Rogero MM
    Int J Food Sci Nutr; 2019 Feb; 70(1):20-29. PubMed ID: 29804478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of probiotics on reducing the colorectal cancer surgery complications: A periodic review during 2007-2017.
    Darbandi A; Mirshekar M; Shariati A; Moghadam MT; Lohrasbi V; Asadolahi P; Talebi M
    Clin Nutr; 2020 Aug; 39(8):2358-2367. PubMed ID: 31831184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.
    Currò D; Ianiro G; Pecere S; Bibbò S; Cammarota G
    Br J Pharmacol; 2017 Jun; 174(11):1426-1449. PubMed ID: 27696378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probiotics for induction of remission in ulcerative colitis.
    Kaur L; Gordon M; Baines PA; Iheozor-Ejiofor Z; Sinopoulou V; Akobeng AK
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD005573. PubMed ID: 32128795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probiotics, Prebiotics, and Synbiotics for the Treatment and Prevention of Adult Dermatological Diseases.
    Notay M; Foolad N; Vaughn AR; Sivamani RK
    Am J Clin Dermatol; 2017 Dec; 18(6):721-732. PubMed ID: 28681230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review.
    Chlebicz-Wójcik A; Śliżewska K
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probiotics, prebiotics, and synbiotics supplementation in prediabetes: protocol for a systematic review and meta-analysis.
    Du X; Xie C; Shi L; Gao H; Yang C; Liu Q
    Medicine (Baltimore); 2020 Mar; 99(13):e19708. PubMed ID: 32221098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prebiotics and synbiotics in ulcerative colitis.
    Laurell A; Sjöberg K
    Scand J Gastroenterol; 2017 Apr; 52(4):477-485. PubMed ID: 27931127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do probiotics, prebiotics and synbiotics affect adiponectin and leptin in adults? A systematic review and meta-analysis of clinical trials.
    Rouhani MH; Hadi A; Ghaedi E; Salehi M; Mahdavi A; Mohammadi H
    Clin Nutr; 2019 Oct; 38(5):2031-2037. PubMed ID: 30352747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease.
    Derwa Y; Gracie DJ; Hamlin PJ; Ford AC
    Aliment Pharmacol Ther; 2017 Aug; 46(4):389-400. PubMed ID: 28653751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of Saccharomyces boulardii as a treatment option in IBD.
    Sivananthan K; Petersen AM
    Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):465-475. PubMed ID: 29771163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probiotics and prebiotics in Crohn's disease therapies.
    Lichtenstein L; Avni-Biron I; Ben-Bassat O
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):81-8. PubMed ID: 27048899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children.
    Guandalini S; Cernat E; Moscoso D
    Benef Microbes; 2015; 6(2):209-17. PubMed ID: 25391345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probiotic treatments for induction and maintenance of remission in inflammatory bowel diseases: a meta-analysis of randomized controlled trials.
    Fujiya M; Ueno N; Kohgo Y
    Clin J Gastroenterol; 2014 Feb; 7(1):1-13. PubMed ID: 26183502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis of randomized controlled trials of the effects of synbiotics, probiotics, or prebiotics in controlling glucose homeostasis in non-alcoholic fatty liver disease patients.
    Ding S; Hong Q; Yao Y; Gu M; Cui J; Li W; Zhang J; Zhang C; Jiang J; Hu Y
    Food Funct; 2024 Sep; 15(19):9954-9971. PubMed ID: 39264166
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of Synbiotics for Ulcerative Colitis Treatment.
    Roselli M; Finamore A
    Curr Clin Pharmacol; 2020; 15(3):174-182. PubMed ID: 31878863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.